Advertisement

Renal Artery Stenosis

  • William R. ColyerJr.
  • Mohammed Taleb
  • Christopher J. Cooper
Chapter

Abstract

Renal artery stenosis (RAS) is a common problem in patients with peripheral or coronary artery disease and is present in roughly 1–5 % of the 60 million Americans with hypertension. Furthermore, as the population ages, the prevalence increases. In the elderly, renal artery stenosis becomes far more common, with an incidence in patients over the age of 65 nearly 7 %. Historically this has been seen as a blood pressure problem, to a large extent based upon the seminal works of Goldblatt and colleagues. Substantial progress has been made in the understanding of the role of the angiotensin, aldosterone, sympathetic, prostaglandin, and oxidant systems in blood pressure regulation. In fact in the past decade, there is increasing awareness that for many patients, blood pressure can be effectively controlled with medications, albeit oftentimes several medications are required to control pressure. Unfortunately renal dysfunction is commonplace, and more importantly, patients with renal dysfunction have a strikingly high rate of adverse cardiovascular events.

Keywords

Renal Artery Renal Artery Stenosis Embolic Protection Device Poststenotic Dilation Significant Renal Artery Stenosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–5151.PubMedCrossRefGoogle Scholar
  2. 2.
    Miralles M, Corominas A, Cotillas J, Castro F, Clara A, Vidal-Barraquer F. Screening for carotid and renal artery stenoses in patients with aortoiliac disease. Ann Vasc Surg. 1998;12:17–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Valentine RJ, Clagett GP, Miller GL, Myers SI, Martin JD, Chervu A. The coronary risk of unsuspected renal artery stenosis. J Vasc Surg. 1993;18:433–9; discussion 439–40.PubMedCrossRefGoogle Scholar
  4. 4.
    Crowley JJ, Santos RM, Peter RH, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J. 1998;136:913–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994;32:8–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608–16.PubMedGoogle Scholar
  7. 7.
    Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344:237–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Ram CV. Renovascular hypertension. Curr Opin Nephrol Hypertens. 1997;6:575–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens Suppl. 1988;6:S3–9.PubMedGoogle Scholar
  10. 10.
    Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldblatt H, Lynch J, Hanzal RF, Summervile WW. Studies on experimental hypertension: production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exper Med. 1934;59:347–79.CrossRefGoogle Scholar
  12. 12.
    Pickering TG. Renovascular hypertension: etiology and pathophysiology. Semin Nucl Med. 1989;19:79–88.PubMedCrossRefGoogle Scholar
  13. 13.
    Kennedy DJ, Colyer WR, Brewster PS, et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926–35.PubMedCrossRefGoogle Scholar
  14. 14.
    Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11:1277–85.PubMedGoogle Scholar
  15. 15.
    Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13:I80–93.PubMedCrossRefGoogle Scholar
  16. 16.
    Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56:2214–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974–80.PubMedCrossRefGoogle Scholar
  19. 19.
    McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679–84.PubMedCrossRefGoogle Scholar
  20. 20.
    Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;17:1743–50.PubMedCrossRefGoogle Scholar
  22. 22.
    Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46:245–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Holley KE, Hunt JC, Brown Jr AL, Kincaid OW, Sheps SG. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med. 1964;37:14–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv. 2009;2:161–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Yu H, Zhang D, Haller S, et al. Determinants of renal function in patients with renal artery stenosis. Vasc Med. 2011;16:331–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64–71.PubMedCrossRefGoogle Scholar
  29. 29.
    Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59–66.PubMedCrossRefGoogle Scholar
  30. 30.
    Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78–85.PubMedGoogle Scholar
  31. 31.
    Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(840–8):W150–1.Google Scholar
  35. 35.
    White CJ. Kiss my astral: one seriously flawed study of renal stenting after another. Catheter Cardiovasc Interv. 2010;75:305–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Modrall JG, Rosero EB, Smith ST, et al. Operative mortality for renal artery bypass in the United States: results from the National Inpatient Sample. J Vasc Surg. 2008;48:317–22.PubMedCrossRefGoogle Scholar
  37. 37.
    Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg. 2005;41:1026–30.PubMedCrossRefGoogle Scholar
  38. 38.
    Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38:962–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117:2752–60.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • William R. ColyerJr.
    • 1
  • Mohammed Taleb
    • 1
    • 2
  • Christopher J. Cooper
    • 1
  1. 1.The Division of Cardiovascular Medicine, Department of MedicineUniversity of ToledoToledoUSA
  2. 2.Department of CardiologyUniversity of Toledo Medical CenterToledoUSA

Personalised recommendations